Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Prevalence of positive ppd in a cohort of rheumatoid arthritis patients.

Tamborenea MN, Tate G, Mysler E, Debonis J, Schijedman A.

Rheumatol Int. 2010 Mar;30(5):613-6. doi: 10.1007/s00296-009-1027-z. Epub 2009 Jul 4.

PMID:
19578852
2.

Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis.

Lee KH, Jung SY, Ha YJ, Lee SK, Park YB.

Rheumatol Int. 2012 May;32(5):1421-4. doi: 10.1007/s00296-011-1889-8. Epub 2011 Mar 27.

PMID:
21442172
3.

Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.

Murakami S, Takeno M, Kirino Y, Kobayashi M, Watanabe R, Kudo M, Ihata A, Ueda A, Ohno S, Watanuki Y, Kaneko T, Ishigatsubo Y.

Tuberculosis (Edinb). 2009 Mar;89(2):136-41. doi: 10.1016/j.tube.2008.12.004. Epub 2009 Feb 10.

PMID:
19211305
4.

Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Marques CD, Duarte ÂL, de Lorena VM, Souza JR, Souza WV, Gomes Yde M, de Carvalho EM.

Rheumatol Int. 2009 Nov;30(1):57-62. doi: 10.1007/s00296-009-0910-y.

PMID:
19363612
5.

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.

Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H.

J Rheumatol. 2009 Dec;36(12):2675-81. doi: 10.3899/jrheum.090268. Epub 2009 Nov 16.

PMID:
19918035
6.

Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.

Janis EM, Allen DW, Glesby MJ, Carey LA, Mundy LM, Gopalan R, Chaisson RE.

Am J Med. 1996 Feb;100(2):186-92.

PMID:
8629653
7.

Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza.

Callado MR, Lima JR, Nobre CA, Vieira WP.

Rev Bras Reumatol. 2011 Jan-Feb;51(1):40-52. English, Portuguese.

8.

Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.

Bélard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, Thomsen H, Brylov A, Hetland ML, Nordgaard-Lassen I, Ravn P.

Inflamm Bowel Dis. 2011 Nov;17(11):2340-9. doi: 10.1002/ibd.21605. Epub 2011 Feb 11.

PMID:
21319275
9.
10.

Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.

Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D.

JAMA. 1992 Jan 15;267(3):369-73.

PMID:
1727959
11.

Oral tuberculosis in a patient with rheumatoid arthritis after long treatment with methotrexate and adalimumab.

Barouta G, Karapetsa M, Kostopoulou E, Alexiou I, Koukoulis G, Sakkas LI.

J Clin Rheumatol. 2010 Oct;16(7):330-1. doi: 10.1097/RHU.0b013e3181f3c003.

PMID:
20859224
12.

Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.

Chen DY, Shen GH, Chen YM, Chen HH, Lin CC, Hsieh CW, Lan JL.

Int J Tuberc Lung Dis. 2011 Feb;15(2):192-200.

PMID:
21219680
13.
14.

Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.

Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A, Cucho M, Alfaro J, Perich R, Pastor C, Harrison J, Sánchez-Schwartz C.

Ann Rheum Dis. 2005 Sep;64(9):1360-1.

15.

Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDs.

Cuppen BV, Jacobs JW, Ter Borg EJ, Marijnissen AC, Bijlsma JW, Lafeber FP, van Laar JM; all SRU investigators.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):221-228. Epub 2016 Oct 7.

16.

Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.

Martin J, Walsh C, Gibbs A, McDonnell T, Fearon U, Keane J, Codd MB, Dodd J, Veale D, Fitzgerald O, Bresnihan B.

Ann Rheum Dis. 2010 Jan;69(1):181-5. doi: 10.1136/ard.2008.101857.

PMID:
19176545
17.

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.

Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):624-32. doi: 10.1002/acr.22510.

18.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

19.

Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.

Park JH, Seo GY, Lee JS, Kim TH, Yoo DH.

J Rheumatol. 2009 Oct;36(10):2158-63. doi: 10.3899/jrheum.090150. Epub 2009 Sep 1.

PMID:
19723901

Supplemental Content

Support Center